# Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer

> **NCT01338012** · PHASE2 · TERMINATED · sponsor: **Dendreon** · enrollment: 8 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** sipuleucel-T

## Key facts

- **NCT ID:** NCT01338012
- **Lead sponsor:** Dendreon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Administrative reasons.
- **Last updated:** 2017-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01338012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01338012, "Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01338012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*